CN106467613A - A kind of self-healing polyanion-chitin quarternary ammonium salt aquagel and its application - Google Patents
A kind of self-healing polyanion-chitin quarternary ammonium salt aquagel and its application Download PDFInfo
- Publication number
- CN106467613A CN106467613A CN201510513817.3A CN201510513817A CN106467613A CN 106467613 A CN106467613 A CN 106467613A CN 201510513817 A CN201510513817 A CN 201510513817A CN 106467613 A CN106467613 A CN 106467613A
- Authority
- CN
- China
- Prior art keywords
- hydrogel
- polyanion
- quaternary ammonium
- chitosan quaternary
- self
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920002101 Chitin Polymers 0.000 title description 2
- 150000003863 ammonium salts Chemical class 0.000 title 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 title 1
- 239000000017 hydrogel Substances 0.000 claims abstract description 62
- 229920001661 Chitosan Polymers 0.000 claims abstract description 55
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims abstract description 33
- 239000000243 solution Substances 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000003814 drug Substances 0.000 claims abstract description 18
- 229940079593 drug Drugs 0.000 claims abstract description 17
- 229920000447 polyanionic polymer Polymers 0.000 claims abstract description 17
- 125000001453 quaternary ammonium group Chemical group 0.000 claims abstract description 15
- 239000012266 salt solution Substances 0.000 claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 9
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 7
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 7
- 238000006243 chemical reaction Methods 0.000 claims abstract description 5
- 239000007787 solid Substances 0.000 claims abstract description 5
- 230000009881 electrostatic interaction Effects 0.000 claims abstract description 4
- 230000017423 tissue regeneration Effects 0.000 claims abstract description 4
- 238000001879 gelation Methods 0.000 claims abstract description 3
- 239000002244 precipitate Substances 0.000 claims abstract description 3
- 239000000499 gel Substances 0.000 claims description 32
- 210000004027 cell Anatomy 0.000 claims description 24
- 239000000463 material Substances 0.000 claims description 21
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 16
- 235000010413 sodium alginate Nutrition 0.000 claims description 16
- 239000000661 sodium alginate Substances 0.000 claims description 16
- 229940005550 sodium alginate Drugs 0.000 claims description 16
- 239000002904 solvent Substances 0.000 claims description 10
- 239000008367 deionised water Substances 0.000 claims description 8
- 229910021641 deionized water Inorganic materials 0.000 claims description 8
- 238000001556 precipitation Methods 0.000 claims description 8
- 238000005119 centrifugation Methods 0.000 claims description 7
- 230000006870 function Effects 0.000 claims description 7
- 230000003068 static effect Effects 0.000 claims description 7
- 238000006467 substitution reaction Methods 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 210000005229 liver cell Anatomy 0.000 claims description 5
- 235000002639 sodium chloride Nutrition 0.000 claims description 5
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 4
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 claims description 4
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 claims description 4
- 210000000130 stem cell Anatomy 0.000 claims description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 3
- 230000003915 cell function Effects 0.000 claims description 3
- 238000005520 cutting process Methods 0.000 claims description 3
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 3
- 241000282412 Homo Species 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 claims description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 2
- 210000001185 bone marrow Anatomy 0.000 claims description 2
- 230000005591 charge neutralization Effects 0.000 claims description 2
- 229960000633 dextran sulfate Drugs 0.000 claims description 2
- 210000002889 endothelial cell Anatomy 0.000 claims description 2
- 238000001125 extrusion Methods 0.000 claims description 2
- 210000002950 fibroblast Anatomy 0.000 claims description 2
- 230000002440 hepatic effect Effects 0.000 claims description 2
- 210000004024 hepatic stellate cell Anatomy 0.000 claims description 2
- 210000001865 kupffer cell Anatomy 0.000 claims description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 2
- 239000001103 potassium chloride Substances 0.000 claims description 2
- 235000011164 potassium chloride Nutrition 0.000 claims description 2
- 239000004323 potassium nitrate Substances 0.000 claims description 2
- 235000010333 potassium nitrate Nutrition 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 2
- 239000004317 sodium nitrate Substances 0.000 claims description 2
- 235000010344 sodium nitrate Nutrition 0.000 claims description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 3
- 239000003960 organic solvent Substances 0.000 abstract description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 abstract 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 abstract 1
- 210000002744 extracellular matrix Anatomy 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 238000004132 cross linking Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000013270 controlled release Methods 0.000 description 3
- 210000003494 hepatocyte Anatomy 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 238000013268 sustained release Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 2
- 229960000907 methylthioninium chloride Drugs 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- MHOFGBJTSNWTDT-UHFFFAOYSA-M 2-[n-ethyl-4-[(6-methoxy-3-methyl-1,3-benzothiazol-3-ium-2-yl)diazenyl]anilino]ethanol;methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC(N(CCO)CC)=CC=C1N=NC1=[N+](C)C2=CC=C(OC)C=C2S1 MHOFGBJTSNWTDT-UHFFFAOYSA-M 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- JUQPZRLQQYSMEQ-UHFFFAOYSA-N CI Basic red 9 Chemical compound [Cl-].C1=CC(N)=CC=C1C(C=1C=CC(N)=CC=1)=C1C=CC(=[NH2+])C=C1 JUQPZRLQQYSMEQ-UHFFFAOYSA-N 0.000 description 1
- 238000005698 Diels-Alder reaction Methods 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229940052223 basic fuchsin Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000004537 potential cytotoxicity Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 229940043267 rhodamine b Drugs 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明公开了一种自愈合聚阴离子-壳聚糖季铵盐水凝胶及其在医药生物领域中的应用。所述水凝胶的制备过程包括:分别配制聚阴离子溶液和壳聚糖季铵盐溶液,将两种溶液充分混合后,两者在静电相互作用下自发聚集,发生凝胶化反应,收集固体沉淀物即获得聚阴离子-壳聚糖季铵盐水凝胶。制备所述水凝胶的原材料来源丰富,价格低廉,该水凝胶生物相容性好,具有自愈合性能,形成过程中避免了有机溶剂,酸碱环境等因素,为其在生物医学领域的应用奠定基础,可用于药物和蛋白定位传递,具有可注射,高粘附性的优点。应用于组织再生支架时,具有制备条件温和,形状可控,含水量高的优点,是一种良好的细胞外基质材料。The invention discloses a self-healing polyanion-chitosan quaternary ammonium hydrogel and its application in the field of medicine and biology. The preparation process of the hydrogel includes: preparing polyanion solution and chitosan quaternary ammonium salt solution respectively, after the two solutions are fully mixed, the two spontaneously aggregate under electrostatic interaction, a gelation reaction occurs, and the solid is collected The precipitate obtained polyanion-chitosan quaternary ammonium hydrogel. The raw materials for preparing the hydrogel are rich in sources and low in price. The hydrogel has good biocompatibility, has self-healing properties, and avoids factors such as organic solvents and acid-base environments during the formation process. It lays the foundation for the application of drugs and proteins, and has the advantages of injectability and high adhesion. When applied to tissue regeneration scaffolds, it has the advantages of mild preparation conditions, controllable shape and high water content, and is a good extracellular matrix material.
Description
技术领域technical field
本发明涉及一种高分子水凝胶,特别是涉及一种自愈合聚阴离子-壳聚糖季铵盐复合水凝胶及其应用。The invention relates to a polymer hydrogel, in particular to a self-healing polyanion-chitosan quaternary ammonium salt composite hydrogel and application thereof.
背景技术Background technique
高分子水凝胶是一种能够吸收并保持大量水的三维网络结构高分子,其内部存在的化学交联或物理交联结构使其只能溶胀而不能溶解。高分子水凝胶具有优异的粘弹性、高含水量和保水率,良好的生物相容性。可应用于农业、食品工程以及生物医学领域。但是由于高分子水凝胶水含量高,受到拉应力或压应力时,均会因为强度低而破坏,难以满足实际应用的需求。Polymer hydrogel is a three-dimensional network structure polymer that can absorb and retain a large amount of water. The chemical cross-linking or physical cross-linking structure inside it can only swell but not dissolve. Polymer hydrogel has excellent viscoelasticity, high water content and water retention rate, and good biocompatibility. It can be applied in the fields of agriculture, food engineering and biomedicine. However, due to the high water content of polymer hydrogel, it will be destroyed due to low strength when subjected to tensile or compressive stress, which is difficult to meet the needs of practical applications.
具有自愈合功能的水凝胶材料有望解决上述问题,适于材料的长期使用。目前主要有两种途径来制备自愈合水凝胶,分别是动态的共价交联和非共价交联。动态共价交联涉及到的化学键包括酰棕键、二硫键和Diels-Alder反应等,这些反应无法自发进行从而限制了它们的应用。另外,复杂的化学合成过程不仅耗时费力,整个过程中引入的特殊化学基团可能诱发毒性反应。利用温和的方法制备生物相容性良好的自愈合水凝胶材料是一个挑战。目前,用天然多糖材料制备具有自愈合性质的水凝胶材料方法非常有限,目前的报道仍然在材料中引入了醛基,具有潜在的细胞毒性[Wei Zhao.Novel BiocompatiblePolysaccharide-Based Self-Healing Hydrogel,Advanced FunctionalMaterials,2015,25(9):1352-1359]。Hydrogel materials with self-healing function are expected to solve the above problems and are suitable for long-term use of materials. Currently, there are mainly two approaches to prepare self-healing hydrogels, namely dynamic covalent crosslinking and noncovalent crosslinking. The chemical bonds involved in dynamic covalent crosslinking include acyl brown bonds, disulfide bonds, and Diels-Alder reactions, etc. These reactions cannot be carried out spontaneously, which limits their applications. In addition, the complicated chemical synthesis process is not only time-consuming and laborious, but the special chemical groups introduced in the whole process may induce toxic reactions. It is a challenge to prepare self-healing hydrogel materials with good biocompatibility using gentle methods. At present, there are very limited methods to prepare hydrogel materials with self-healing properties from natural polysaccharide materials, and the current reports still introduce aldehyde groups into the materials, which have potential cytotoxicity[Wei Zhao.Novel BiocompatiblePolysaccharide-Based Self-Healing Hydrogel , Advanced Functional Materials, 2015, 25(9): 1352-1359].
壳聚糖季铵盐是一种带正电荷的壳聚糖衍生物,具有电荷密度高水溶性好的优点。天然聚阴离子材料和壳聚糖季铵盐可以通过静电相互作用聚集而形成的水凝胶,静电相互作用力是一种非共价键力,在合适的条件下可以发生断裂和修复的过程,为制备自愈合材料提供可能。由于整个过程中使用的都是天然来源的多糖材料,壳聚糖季铵盐的大规模合成技术也非常完善,使得所使用的材料价廉易得,凝胶的制备过程反应条件温和。Chitosan quaternary ammonium salt is a positively charged chitosan derivative, which has the advantages of high charge density and good water solubility. Natural polyanionic materials and chitosan quaternary ammonium salts can form hydrogels through electrostatic interaction. The electrostatic interaction force is a non-covalent bond force, which can break and repair under suitable conditions. It is possible to prepare self-healing materials. Because all the polysaccharide materials of natural origin are used in the whole process, the large-scale synthesis technology of chitosan quaternary ammonium salt is also very perfect, so that the materials used are cheap and easy to obtain, and the reaction conditions of the gel preparation process are mild.
由于水凝胶具有多孔性,药物/蛋白可以缓慢释放,从而实现药物的缓控释[Nathan P.Birch.Thermal-Responsive Behavior of a Cell CompatibleChitosan/Pectin Hydrogel,Biomacromolecules,2015,16(6):1837-1843]。但是块状的凝胶材料不易于植入体内,开发可注射的材料成为解决这一问题的方法,目前常见的是开发具有剪切变稀性质的水凝胶,实现微创移植[Guvendiren,Murat.Shear-thinning hydrogels for biomedicalapplications,Soft Matter,2012,8(2):260-272]。在组织工程领域,模拟细胞微环境其中一个重要的方向,水凝胶的含水量与人体组织接近,开发制备条件温和的水凝胶是保证细胞活性的必要条件。目前常用的是海藻酸钙作为凝胶材料,但是该水凝胶一旦制备完成其形状不能随意变动,不利于后续移植等应用。Due to the porosity of the hydrogel, the drug/protein can be released slowly, thereby realizing the slow and controlled release of the drug [Nathan P.Birch. -1843]. However, bulk gel materials are not easy to implant in the body, and the development of injectable materials has become a solution to this problem. At present, it is common to develop hydrogels with shear-thinning properties to achieve minimally invasive transplantation [Guvendiren, Murat .Shear-thinning hydrogels for biomedical applications, Soft Matter, 2012, 8(2):260-272]. In the field of tissue engineering, one of the important directions of simulating the cell microenvironment, the water content of hydrogel is close to that of human tissue, and the development of hydrogel with mild preparation conditions is a necessary condition to ensure cell activity. At present, calcium alginate is commonly used as the gel material, but once the hydrogel is prepared, its shape cannot be changed at will, which is not conducive to subsequent applications such as transplantation.
发明内容Contents of the invention
本发明的目的是提供一种具有自愈合性质的水凝胶以及其在生物医学领域中的应用,具体为一种自愈合聚阴离子-壳聚糖季铵盐水凝胶,其中,提高溶液的离子强度,能够提高自愈合现象发生的速度,降低凝胶的机械强度。The purpose of the present invention is to provide a kind of hydrogel with self-healing property and its application in biomedical field, specifically a kind of self-healing polyanion-chitosan quaternary ammonium hydrogel, wherein, improve solution A higher ionic strength can increase the speed of the self-healing phenomenon and reduce the mechanical strength of the gel.
本发明的技术方案为:Technical scheme of the present invention is:
一种自愈合聚阴离子-壳聚糖季铵盐水凝胶,制备过程包括:分别配制聚阴离子溶液和壳聚糖季铵盐溶液,将两种溶液充分混合后,两者在静电相互作用下自发聚集,发生凝胶化反应,收集固体沉淀物即获得聚阴离子-壳聚糖季铵盐水凝胶。A self-healing polyanion-chitosan quaternary ammonium hydrogel, the preparation process includes: respectively preparing polyanion solution and chitosan quaternary ammonium salt solution, after the two solutions are fully mixed, the two are electrostatically interacted Spontaneous aggregation, gelation reaction occurs, and the solid precipitate is collected to obtain the polyanion-chitosan quaternary ammonium hydrogel.
水凝胶中聚阴离子与壳聚糖季铵盐的质量比为0.1:1-10:1,优选质量比为0.5:1-2:1,水凝胶的含水量在50-99%之间,一般来说含水量越多机械强度越差,在实际应用中,以含水量在70-80%为最佳。The mass ratio of polyanion and chitosan quaternary ammonium salt in the hydrogel is 0.1:1-10:1, preferably the mass ratio is 0.5:1-2:1, and the water content of the hydrogel is between 50-99% Generally speaking, the higher the water content, the worse the mechanical strength. In practical applications, the best water content is 70-80%.
水凝胶在pH值4-14范围内保持稳定,pH值低于4时,水凝胶丧失自愈合功能。水凝胶在温度0-60℃范围内保持稳定,低于0℃会凝固,高于60℃溶液可能气化。The hydrogel remains stable in the pH range of 4-14, and the hydrogel loses its self-healing function when the pH value is lower than 4. The hydrogel remains stable in the temperature range of 0-60°C, it will solidify below 0°C, and the solution may vaporize above 60°C.
所述的聚阴离子包括海藻酸钠,羧甲基纤维素钠,透明质酸钠,羧甲基壳聚糖,硫酸葡聚糖中的一种或两种以上。The polyanion includes one or more of sodium alginate, sodium carboxymethyl cellulose, sodium hyaluronate, carboxymethyl chitosan and dextran sulfate.
该水凝胶经任意切割处理后,分离的水凝胶再接触后具有自愈合功能,形成一块完整的凝胶材料,切割产生的裂痕消失。After the hydrogel is randomly cut, the separated hydrogel has a self-healing function after being in contact again, forming a complete gel material, and the cracks generated by cutting disappear.
所述的聚阴离子分子量为10kDa-2000kDa;优选分子量范围为100-1000kDa,壳聚糖季铵盐分子量10kDa-2000kDa,优选分子量范围为10-100kDa,取代度50%-100%,优选取代度范围为70%-100%。The molecular weight of the polyanion is 10kDa-2000kDa; the preferred molecular weight range is 100-1000kDa, the molecular weight of chitosan quaternary ammonium salt is 10kDa-2000kDa, the preferred molecular weight range is 10-100kDa, and the degree of substitution is 50%-100%, preferably within the range of degree of substitution 70%-100%.
所述水凝胶制备过程中配制的聚阴离子溶液的溶剂为去离子水,或添加无机盐的水溶液,溶液浓度为0.1-500g/L,优选浓度范围为1-100g/L,最佳浓度范围为1-10g/L;配制的季铵盐溶液的溶剂为去离子水,或添加无机盐的水溶液,溶液浓度为0.1-500g/L,优选浓度范围为1-100g/L,最佳浓度范围为1-10g/L,所述无机盐为氯化钠,硝酸钠,氯化钾,硝酸钾中的一种或两种以上。The solvent of the polyanion solution prepared in the preparation process of the hydrogel is deionized water, or an aqueous solution with inorganic salt added, the solution concentration is 0.1-500g/L, the preferred concentration range is 1-100g/L, and the optimum concentration range is 1-10g/L; the solvent of the prepared quaternary ammonium salt solution is deionized water, or an aqueous solution with inorganic salts added, the solution concentration is 0.1-500g/L, the preferred concentration range is 1-100g/L, the optimal concentration range 1-10g/L, and the inorganic salt is one or more of sodium chloride, sodium nitrate, potassium chloride and potassium nitrate.
所述的固体沉淀收集方法包括静止沉淀,挤压收集和离心收集。The solid precipitation collection method includes static precipitation, extrusion collection and centrifugation collection.
离心收集的离心时间为1-120分钟,离心速率为10-100000rpm。The centrifugation time for centrifugation collection is 1-120 minutes, and the centrifugation rate is 10-100000 rpm.
本发明提供一种自愈合聚阴离子-壳聚糖季铵盐水凝胶在生物医学领域中的应用。The invention provides the application of a self-healing polyanion-chitosan quaternary ammonium hydrogel in the field of biomedicine.
本发明制备的水凝胶无毒、温和、可自愈合,能够但不限制于应用在药物缓释、外敷给药、活细胞的培养等生物医学领域。The hydrogel prepared by the invention is non-toxic, mild and self-healing, and can be used in biomedical fields such as drug sustained release, topical administration, and living cell culture, but not limited to.
所述的生物医学领域中,该水凝胶能够但不限制应用于药物和蛋白定位传递,组织再生支架。该水凝胶应用于药物定位传递时,药物直接与聚阴离子和壳聚糖季铵盐混合,药物终浓度在1μg/ml-1000mg/ml,最佳浓度参考药物的人体所需剂量。In the aforementioned biomedical field, the hydrogel can be applied to, but not limited to, drug and protein localized delivery, and tissue regeneration scaffold. When the hydrogel is used for localized drug delivery, the drug is directly mixed with polyanion and chitosan quaternary ammonium salt, the final concentration of the drug is 1 μg/ml-1000 mg/ml, and the optimal concentration refers to the required dose of the drug for the human body.
该水凝胶应用于组织再生支架时,在37℃条件下进行聚阴离子和壳聚糖季铵盐的混合,以达到电中和为最佳,pH值控制在6.4-7.8之间,pH=7.4最佳。将制备好的凝胶平铺于培养皿,表面接种活细胞,接种的参考密度为1*104-2*105个/cm2,最佳接种密度为4*104个/cm2。所述活细胞为人或动物来源的离体的肝细胞,干细胞,干细胞分化的具有肝细胞功能的细胞,肝细胞系细胞,转分化的具有肝细胞功能的细胞,内皮细胞,肝枯否氏细胞,肝星形细胞,成纤维细胞,骨髓间充质干细胞中一种或二种以上。When the hydrogel is applied to the tissue regeneration scaffold, the polyanion and the chitosan quaternary ammonium salt are mixed at 37°C to achieve the best charge neutralization, and the pH value is controlled between 6.4-7.8, and the pH= 7.4 best. Spread the prepared gel on a petri dish, and inoculate the surface with living cells. The reference density of inoculation is 1*10 4 -2*10 5 cells/cm 2 , and the optimal inoculation density is 4*10 4 cells/cm 2 . The living cells are isolated hepatocytes derived from humans or animals, stem cells, stem cell differentiated cells with hepatocyte function, liver cell line cells, transdifferentiated cells with hepatocyte function, endothelial cells, hepatic Kupffer cells , one or more of hepatic stellate cells, fibroblasts, and bone marrow mesenchymal stem cells.
本发明的有益效果:Beneficial effects of the present invention:
1、本发明的这种复合凝胶具有自愈合功能,该现象可以自发进行,不需要外界刺激。1. The composite gel of the present invention has a self-healing function, which can be performed spontaneously without external stimulation.
2、这种由聚阴离子和壳聚糖季铵盐制备而成的复合物具有离子强度响应性,具体表现在提高溶液的离子强度,能够提高自愈合现象发生的速度,降低凝胶的机械强度。2. This compound prepared by polyanion and chitosan quaternary ammonium salt has ionic strength responsiveness, which is specifically manifested in increasing the ionic strength of the solution, which can increase the speed of self-healing phenomenon and reduce the mechanical strength of the gel. strength.
3、本发明使用的聚阴离子材料来源于天然产物,壳聚糖季铵盐也是在天然产物甲壳素的基础上进行修饰合成的,材料来源丰富,价格低廉,生物相容性好,可以自愈合,另外水凝胶的形成过程中避免了有机溶剂,酸碱环境等因素,为其在生物医学领域的应用奠定基础。作为药物释放载体时,该水凝胶材料具有缓控释的作用。由于凝胶具有剪切变稀的效果,因此可以用于注射,结合材料可以自愈合的作用,能够通过注射的方法定点给药,材料在体内形成块状凝胶。另外,该水凝胶具有很强的粘附性能,能够粘附在多种材料表面上,可以作为敷料给药。应用于组织工程支架时,水凝胶的形状容易控制,制备条件温和,结合凝胶的高含水率特性,可以模拟细胞微环境,促进细胞的增殖和生长。3. The polyanion material used in the present invention is derived from natural products. The chitosan quaternary ammonium salt is also modified and synthesized on the basis of the natural product chitin. The source of the material is abundant, the price is low, the biocompatibility is good, and it can heal itself In addition, organic solvents, acid-base environment and other factors are avoided during the formation of hydrogels, which lays the foundation for its application in the field of biomedicine. When used as a drug release carrier, the hydrogel material has the effect of sustained and controlled release. Because the gel has the effect of shear thinning, it can be used for injection, combined with the self-healing effect of the material, it can be administered at a fixed point through the injection method, and the material forms a block gel in the body. In addition, the hydrogel has strong adhesive properties, can adhere to the surface of various materials, and can be used as a dressing for drug administration. When applied to tissue engineering scaffolds, the shape of the hydrogel is easy to control, and the preparation conditions are mild. Combined with the high water content of the gel, it can simulate the cell microenvironment and promote cell proliferation and growth.
附图说明Description of drawings
图1为海藻酸钠-壳聚糖季铵盐凝胶的自愈合;Fig. 1 is the self-healing of sodium alginate-chitosan quaternary ammonium salt gel;
图2为羧甲基壳聚糖-壳聚糖季铵盐凝胶的3ITT流变实验;Fig. 2 is the 3ITT rheological experiment of carboxymethyl chitosan-chitosan quaternary ammonium salt gel;
图3为凝胶表面的细胞死/活染色。Figure 3. Cell dead/live staining of the surface of the gel.
具体实施方式detailed description
为更好的理解本发明,下面结合附图和实施例对本发明作进一步的说明,但本发明的实施方案不限于此。For a better understanding of the present invention, the present invention will be further described below in conjunction with the accompanying drawings and examples, but the embodiments of the present invention are not limited thereto.
实施例1Example 1
(1)配制海藻酸钠和壳聚糖季铵盐溶液,浓度分别为20g/L和40g/L,溶剂为去离子水。海藻酸钠分子量430kDa,G片段含量35%。壳聚糖季铵盐取代度85%,分子量78kDa。(1) Prepare sodium alginate and chitosan quaternary ammonium salt solutions, the concentrations are respectively 20g/L and 40g/L, and the solvent is deionized water. Sodium alginate has a molecular weight of 430kDa and a G fragment content of 35%. The degree of substitution of chitosan quaternary ammonium salt is 85%, and the molecular weight is 78kDa.
(2)震荡条件下将壳聚糖季铵盐溶液加入到等体积的海藻酸钠溶液中,充分震荡混匀。(2) Add the chitosan quaternary ammonium salt solution into an equal volume of sodium alginate solution under shaking conditions, shake and mix well.
(3)静止沉淀2小时收集产物。形成的凝胶分别用红色的碱性品红和蓝色的亚甲基蓝染色,两块颜色不同的饼状凝胶被均匀的分成4份,按照颜色交错的原则重新摆放,使切开的两块凝胶靠近。此后不同时间分别观察凝胶状态。结果如图1所示,相互靠近的两块凝胶在接触1小时后边界开始模糊,7小时后完全融合形成一块完整的凝胶。(3) Static precipitation for 2 hours to collect the product. The formed gels were stained with red basic fuchsin and blue methylene blue respectively, and the two cake-like gels with different colors were evenly divided into 4 parts, and rearranged according to the principle of staggered colors, so that the cut two pieces Gel close up. Thereafter, the gel state was observed at different times. The results are shown in Figure 1. The boundaries of the two gels close to each other began to blur after 1 hour of contact, and completely fused to form a complete gel after 7 hours.
实施例2Example 2
(1)配制羧甲基纤维素钠和壳聚糖季铵盐溶液,质量分数均为20g/L,溶剂为去离子水。羧甲基纤维素钠分子量500kDa。壳聚糖季铵盐取代度85%,分子量78kDa。(1) Prepare carboxymethylcellulose sodium and chitosan quaternary ammonium salt solutions, the mass fraction is 20g/L, and the solvent is deionized water. The molecular weight of sodium carboxymethyl cellulose is 500kDa. The degree of substitution of chitosan quaternary ammonium salt is 85%, and the molecular weight is 78kDa.
(2)震荡条件下将壳聚糖季铵盐溶液加入到等体积的海藻酸钠溶液中,充分震荡混匀。(2) Add the chitosan quaternary ammonium salt solution into an equal volume of sodium alginate solution under shaking conditions, shake and mix well.
(3)静止沉淀2小时收集产物,进行流变学分析,如图2所示,通过提高应变,凝胶的结构被破坏,将应力降低后凝胶的结构迅速恢复,储能模量恢复至原来的65%以上。(3) Static sedimentation for 2 hours to collect the product and carry out rheological analysis, as shown in Figure 2, by increasing the strain, the structure of the gel is destroyed, and the structure of the gel is quickly restored after the stress is reduced, and the storage modulus returns to More than 65% of the original.
实施例3Example 3
(1)配制海藻酸钠和壳聚糖季铵盐溶液,浓度分别为20g/L和40g/L,溶剂为去离子水。海藻酸钠分子量430kDa,G片段含量35%。壳聚糖季铵盐取代度85%,分子量78kDa。(1) Prepare sodium alginate and chitosan quaternary ammonium salt solutions, the concentrations are respectively 20g/L and 40g/L, and the solvent is deionized water. Sodium alginate has a molecular weight of 430kDa and a G fragment content of 35%. The degree of substitution of chitosan quaternary ammonium salt is 85%, and the molecular weight is 78kDa.
(2)震荡条件下将壳聚糖季铵盐溶液加入到等体积的海藻酸钠溶液中,充分震荡混匀。(2) Add the chitosan quaternary ammonium salt solution into an equal volume of sodium alginate solution under shaking conditions, shake and mix well.
(3)静止沉淀2小时收集产物。形成的凝胶分别与水溶性的亚甲基蓝和油溶性的罗丹明B混合,最终的药物浓度为0.1g/L。(3) Static precipitation for 2 hours to collect the product. The formed gel was mixed with water-soluble methylene blue and oil-soluble rhodamine B respectively, and the final drug concentration was 0.1 g/L.
(4)收集1mL凝胶置于10mL磷酸缓冲液(pH=7.4)中,25℃条件下两种药物均表现出先快后慢的释放行为,24h时药物释放量达到50%,7天后药物释放量可以达到90%以上,表明水凝胶具有良好的缓控释效果。(4) Collect 1 mL of the gel and place it in 10 mL of phosphate buffer (pH=7.4). At 25°C, the two drugs both exhibit fast and then slow release behavior. The drug release reaches 50% in 24 hours, and the drug is released after 7 days. The content can reach more than 90%, indicating that the hydrogel has a good sustained and controlled release effect.
实施例4Example 4
(1)配制海藻酸钠和壳聚糖季铵盐溶液,浓度分别为20g/L和40g/L,溶剂为去离子水。海藻酸钠分子量430kDa,G片段含量35%。壳聚糖季铵盐取代度85%,分子量78kDa。(1) Prepare sodium alginate and chitosan quaternary ammonium salt solutions, the concentrations are respectively 20g/L and 40g/L, and the solvent is deionized water. Sodium alginate has a molecular weight of 430kDa and a G fragment content of 35%. The degree of substitution of chitosan quaternary ammonium salt is 85%, and the molecular weight is 78kDa.
(2)震荡条件下将壳聚糖季铵盐溶液加入到等体积的海藻酸钠溶液中,充分震荡混匀。(2) Add the chitosan quaternary ammonium salt solution into an equal volume of sodium alginate solution under shaking conditions, shake and mix well.
(3)静止沉淀2小时收集产物,取1mL产物经冷冻干燥处理。(3) The product was collected by static precipitation for 2 hours, and 1 mL of the product was freeze-dried.
(4)干燥的凝胶置于10mL磷酸缓冲液(pH=7.4)中,25℃条件下6h凝胶吸水达到平衡,含水量约75%左右。(4) The dried gel was placed in 10 mL of phosphate buffer (pH=7.4), and the gel absorbed water to reach equilibrium at 25°C for 6 hours, and the water content was about 75%.
(5)如图3所示,灭菌后的凝胶平铺在小皿中,表面接种HepG2细胞,经过24h培养后,细胞贴在凝胶表面,经死活染色处理,细胞活性保持在95%以上。(5) As shown in Figure 3, the sterilized gel was tiled in a small dish, and HepG2 cells were inoculated on the surface. After 24 hours of cultivation, the cells were attached to the surface of the gel, and the cell viability remained above 95% after dying and dying staining. .
(6)对该细胞功能表征,一周后细胞活性保持在80%,白蛋白分泌量为0.46±0.05μg/106个细胞,尿素合成量为231±29μg/106个细胞。(6) The cell function was characterized, and after one week, the cell activity remained at 80%, the albumin secretion was 0.46±0.05 μg/10 6 cells, and the urea synthesis was 231±29 μg/10 6 cells.
比较例1Comparative example 1
(1)配制海藻酸钠和壳聚糖溶液,浓度分别为20g/L和40g/L。海藻酸钠分子量430kDa,G片段含量35%。壳聚糖的脱乙酰度85%,分子量78kDa。配制海藻酸钠的溶剂为水,配制壳聚糖的溶剂为1%醋酸。(1) Sodium alginate and chitosan solutions were prepared with concentrations of 20g/L and 40g/L respectively. Sodium alginate has a molecular weight of 430kDa and a G fragment content of 35%. The degree of deacetylation of chitosan is 85%, and the molecular weight is 78kDa. The solvent for preparing sodium alginate is water, and the solvent for preparing chitosan is 1% acetic acid.
(2)震荡条件下将壳聚糖溶液加入到等体积的海藻酸钠溶液中,充分震荡混匀。(2) Add the chitosan solution into an equal volume of sodium alginate solution under shaking conditions, shake and mix well.
(3)静止沉淀2小时收集产物水凝胶。(3) Static precipitation for 2 hours to collect the product hydrogel.
(4)灭菌后的凝胶平铺在小皿中,表面接种鼠来源的L929细胞,经过24h培养后,细胞贴在凝胶表面,经死活染色处理,细胞活性下降至20%以下。由于壳聚糖在水溶液中的溶解度低,醋酸的添加能够增加壳聚糖的溶解度,同时过酸环境会导致细胞失活。(4) The sterilized gel was tiled in a small dish, and the surface was inoculated with mouse-derived L929 cells. After 24 hours of culture, the cells were attached to the surface of the gel, and the cell viability decreased to less than 20% after life and death staining. Due to the low solubility of chitosan in aqueous solution, the addition of acetic acid can increase the solubility of chitosan, while the overacid environment will lead to cell inactivation.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510513817.3A CN106467613B (en) | 2015-08-19 | 2015-08-19 | A self-healing polyanion-chitosan quaternary ammonium hydrogel and its application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510513817.3A CN106467613B (en) | 2015-08-19 | 2015-08-19 | A self-healing polyanion-chitosan quaternary ammonium hydrogel and its application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106467613A true CN106467613A (en) | 2017-03-01 |
CN106467613B CN106467613B (en) | 2019-01-25 |
Family
ID=58228835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510513817.3A Active CN106467613B (en) | 2015-08-19 | 2015-08-19 | A self-healing polyanion-chitosan quaternary ammonium hydrogel and its application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106467613B (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106913583A (en) * | 2017-04-20 | 2017-07-04 | 深圳市赛欧细胞生物科技有限公司 | The preparation method and application of human mesenchymal stem cell source excretion body biologically active agents |
CN107217034A (en) * | 2017-04-20 | 2017-09-29 | 深圳市赛欧细胞生物科技有限公司 | A kind of human umbilical cord mesenchymal stem cells source excretion body and its acquisition methods and application |
CN107973874A (en) * | 2017-11-27 | 2018-05-01 | 北京大学 | A kind of high adherence conduction self-healing hydrogel and its preparation method and application |
CN109022342A (en) * | 2018-09-18 | 2018-12-18 | 海安百优基质生物工程有限公司 | The dimensional culture system cultivated using chiral hydrogel as attached cell |
CN109512579A (en) * | 2018-10-08 | 2019-03-26 | 武汉纺织大学 | A kind of multilayer moisture absorption is breathed freely magnetic therapy and intelligent temperature control type dressing and application method |
CN110974778A (en) * | 2019-05-14 | 2020-04-10 | 暨南大学 | A kind of sustained-release microgel ointment with high drug loading and preparation method and application thereof |
CN111388755A (en) * | 2020-03-20 | 2020-07-10 | 东华大学 | Injectable hyaluronic acid/chitosan hydrogel and preparation method thereof |
CN111518289A (en) * | 2020-05-21 | 2020-08-11 | 山东大学 | Injectable self-healing hydrogel with adjustable mechanical properties and preparation method and application thereof |
CN112062974A (en) * | 2020-08-04 | 2020-12-11 | 广东省医疗器械研究所 | Rapidly-formed injectable multifunctional hydrogel and preparation method and application thereof |
CN113372584A (en) * | 2021-06-28 | 2021-09-10 | 南京林业大学 | Preparation method of hydrogel based on carboxymethyl chitosan and having self-healing performance |
CN114652895A (en) * | 2020-12-23 | 2022-06-24 | 上海其胜生物制剂有限公司 | Preparation method of injectable tissue regeneration type chitosan composite gel scaffold |
CN114885967A (en) * | 2022-05-25 | 2022-08-12 | 杭州富春食品添加剂有限公司 | Process for preparing glycerin monostearate emulsifier by molecular distillation |
CN115124739A (en) * | 2022-07-12 | 2022-09-30 | 自然资源部第三海洋研究所 | Injectable marine polysaccharide full-physical crosslinked hydrogel and preparation method thereof |
CN118005989A (en) * | 2024-03-07 | 2024-05-10 | 上海乐纯生物技术股份有限公司 | Porous microcarrier and production and manufacturing method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1830420A (en) * | 2005-03-08 | 2006-09-13 | 中国科学院过程工程研究所 | A kind of injectable pH sensitive chitosan quaternary ammonium hydrogel and preparation method thereof |
CN101099728A (en) * | 2007-07-26 | 2008-01-09 | 复旦大学 | A kind of mucoadhesive nanoparticle-hydrogel film drug delivery system and its preparation method |
CN101507830A (en) * | 2009-03-20 | 2009-08-19 | 武汉锐尔生物科技有限公司 | Hydrocolloid for dressing and preparation method thereof |
CN102764447A (en) * | 2012-07-27 | 2012-11-07 | 武汉人福医疗用品有限公司 | Hydrogel dressing and preparation process thereof |
-
2015
- 2015-08-19 CN CN201510513817.3A patent/CN106467613B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1830420A (en) * | 2005-03-08 | 2006-09-13 | 中国科学院过程工程研究所 | A kind of injectable pH sensitive chitosan quaternary ammonium hydrogel and preparation method thereof |
CN101099728A (en) * | 2007-07-26 | 2008-01-09 | 复旦大学 | A kind of mucoadhesive nanoparticle-hydrogel film drug delivery system and its preparation method |
CN101507830A (en) * | 2009-03-20 | 2009-08-19 | 武汉锐尔生物科技有限公司 | Hydrocolloid for dressing and preparation method thereof |
CN102764447A (en) * | 2012-07-27 | 2012-11-07 | 武汉人福医疗用品有限公司 | Hydrogel dressing and preparation process thereof |
Non-Patent Citations (1)
Title |
---|
《NATURE》 * |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107217034A (en) * | 2017-04-20 | 2017-09-29 | 深圳市赛欧细胞生物科技有限公司 | A kind of human umbilical cord mesenchymal stem cells source excretion body and its acquisition methods and application |
CN106913583A (en) * | 2017-04-20 | 2017-07-04 | 深圳市赛欧细胞生物科技有限公司 | The preparation method and application of human mesenchymal stem cell source excretion body biologically active agents |
CN107973874A (en) * | 2017-11-27 | 2018-05-01 | 北京大学 | A kind of high adherence conduction self-healing hydrogel and its preparation method and application |
CN107973874B (en) * | 2017-11-27 | 2020-06-02 | 北京大学 | A kind of high-adhesion conductive self-healing hydrogel and its preparation method and application |
CN109022342A (en) * | 2018-09-18 | 2018-12-18 | 海安百优基质生物工程有限公司 | The dimensional culture system cultivated using chiral hydrogel as attached cell |
CN109512579A (en) * | 2018-10-08 | 2019-03-26 | 武汉纺织大学 | A kind of multilayer moisture absorption is breathed freely magnetic therapy and intelligent temperature control type dressing and application method |
CN109512579B (en) * | 2018-10-08 | 2022-02-18 | 武汉纺织大学 | Multi-layer moisture-absorption breathable magnetic therapy and intelligent temperature control type dressing and using method |
CN110974778B (en) * | 2019-05-14 | 2021-06-11 | 暨南大学 | High-drug-loading-rate slow-release microgel ointment and preparation method and application thereof |
CN110974778A (en) * | 2019-05-14 | 2020-04-10 | 暨南大学 | A kind of sustained-release microgel ointment with high drug loading and preparation method and application thereof |
CN111388755A (en) * | 2020-03-20 | 2020-07-10 | 东华大学 | Injectable hyaluronic acid/chitosan hydrogel and preparation method thereof |
CN111518289A (en) * | 2020-05-21 | 2020-08-11 | 山东大学 | Injectable self-healing hydrogel with adjustable mechanical properties and preparation method and application thereof |
CN111518289B (en) * | 2020-05-21 | 2021-11-19 | 山东大学 | Injectable self-healing hydrogel with adjustable mechanical properties and preparation method and application thereof |
CN112062974A (en) * | 2020-08-04 | 2020-12-11 | 广东省医疗器械研究所 | Rapidly-formed injectable multifunctional hydrogel and preparation method and application thereof |
CN114652895A (en) * | 2020-12-23 | 2022-06-24 | 上海其胜生物制剂有限公司 | Preparation method of injectable tissue regeneration type chitosan composite gel scaffold |
CN113372584A (en) * | 2021-06-28 | 2021-09-10 | 南京林业大学 | Preparation method of hydrogel based on carboxymethyl chitosan and having self-healing performance |
CN113372584B (en) * | 2021-06-28 | 2022-03-22 | 南京林业大学 | A kind of preparation method of hydrogel based on carboxymethyl chitosan and having self-healing performance |
CN114885967A (en) * | 2022-05-25 | 2022-08-12 | 杭州富春食品添加剂有限公司 | Process for preparing glycerin monostearate emulsifier by molecular distillation |
CN115124739A (en) * | 2022-07-12 | 2022-09-30 | 自然资源部第三海洋研究所 | Injectable marine polysaccharide full-physical crosslinked hydrogel and preparation method thereof |
CN118005989A (en) * | 2024-03-07 | 2024-05-10 | 上海乐纯生物技术股份有限公司 | Porous microcarrier and production and manufacturing method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN106467613B (en) | 2019-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106467613A (en) | A kind of self-healing polyanion-chitin quarternary ammonium salt aquagel and its application | |
Teng et al. | Recent development of alginate-based materials and their versatile functions in biomedicine, flexible electronics, and environmental uses | |
CN102942660B (en) | Natural biological crosslinking nanocomposite three-dimensional gel bracket and preparation method | |
Silva et al. | Ionic liquids in the processing and chemical modification of chitin and chitosan for biomedical applications | |
CN103656729B (en) | Hydrogel based on gamma-polyglutamic acid and polylysine cross-linked polymer and preparation method thereof | |
Patil et al. | Ionotropic gelation and polyelectrolyte complexation: the novel techniques to design hydrogel particulate sustained, modulated drug delivery system: a review | |
CN107137765B (en) | Polypyrrole biological conductive hydrogel and preparation method and application thereof | |
TW458987B (en) | Poly-β-1→4-N-acetylglucosamine | |
CA3059120C (en) | Hydrogel for cell culture and biomedical applications | |
Sun et al. | Covalently crosslinked hyaluronic acid‐chitosan hydrogel containing dexamethasone as an injectable scaffold for soft tissue engineering | |
CN106947094A (en) | Sensitive selfreparing hydrogels of a kind of pH and preparation method thereof | |
CN106474530A (en) | A kind of preparation method of the polyelectrolyte sponge bleeding-stopping dressing based on chitosan oligosaccharide | |
CN105169474A (en) | Polypeptide material capable of carrying out self-assembly to form hydrogel under neutral pH condition and applications thereof | |
CN103524795A (en) | Thermo-sensitive type injectable chitosan hydrogel product and applications thereof | |
CN100522247C (en) | Injectable temperature-sensitive chitosan/methyl cellulose gel and its preparation process | |
CN106474523A (en) | Preparation method based on the polyelectrolyte sponge wound dressing of carboxymethyl chitosan | |
CN105148322B (en) | Injection aquagel and preparation method thereof | |
CN104548200B (en) | Method of preparing highly branched polysaccharide-fibroin hydrogel bracket | |
CN103638562A (en) | Cartilage tissue engineering scaffold material and preparation method thereof | |
Zhang et al. | Polysaccharide based supramolecular injectable hydrogels for in situ treatment of bladder cancer | |
US20030119157A1 (en) | Macroporous chitosan beads and preparation method thereof | |
CN101130107A (en) | A kind of chitosan/polyvinyl alcohol gel containing hydroxyapatite nanoparticles and its preparation method and application | |
CN105169491B (en) | A kind of method for preparing fungi highly -branched polysaccharide xanthan gum hydrogel scaffold | |
CN102517211B (en) | Quickly-dissociative three-dimensional cell culture carrier and its preparation method | |
An et al. | A mechanically adaptive “all-sugar” hydrogel for cell-laden injection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |